According to GlaxoSmithKline's latest financial reports and stock price the company's current Operating Margin is 19.52%. At the end of 2021 the company had an Operating Margin of 18.23%.
Year | Operating Margin | Change |
---|---|---|
2021 | 18.23% | -20.55% |
2020 | 22.94% | 8.99% |
2019 | 21.05% | 16.47% |
2018 | 18.08% | 28.05% |
2017 | 14.12% | 48.22% |
2016 | 9.52% | -79.77% |
2015 | 47.07% | 195% |
2014 | 15.96% | -42.75% |
2013 | 27.87% | -1.15% |
2012 | 28.19% | -9.13% |
2011 | 31.03% | 120.88% |
2010 | 14.05% | -54.06% |
2009 | 30.58% | -0.75% |
2008 | 30.81% | -14.58% |
2007 | 36.06% | 7.28% |
2006 | 33.62% | 1901.06% |
2005 | 1.68% | -94.44% |
2004 | 30.21% | 1.33% |
2003 | 29.81% | 10.7% |
2002 | 26.93% | -9.4% |
2001 | 29.72% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
![]() Novartis NVS | 16.15% | -17.26% | ๐จ๐ญ Switzerland |
![]() Pfizer PFE | 29.90% | 53.18% | ๐บ๐ธ USA |
![]() Sanofi SNY | 19.90% | 1.95% | ๐ซ๐ท France |
![]() Merck MRK | 28.49% | 45.95% | ๐บ๐ธ USA |
![]() AstraZeneca AZN | -0.70% | -103.59% | ๐ฌ๐ง UK |
![]() Teva Pharmaceutical Industries TEVA | 4.14% | -78.79% | ๐ฎ๐ฑ Israel |
![]() Dynavax Technologies
DVAX | 17.64% | -9.63% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.